HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lian-Ping He Selected Research

Lian-Ping He Research Topics

Disease

3Obesity
05/2022 - 12/2013
2Neoplasms (Cancer)
01/2021 - 01/2014
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2022
1Lung Neoplasms (Lung Cancer)
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Asthma (Bronchial Asthma)
02/2015
1Female Infertility
01/2015
1Squamous Cell Carcinoma of Head and Neck
01/2014
1Neoplasm Metastasis (Metastasis)
01/2014
1Overweight
12/2013
1Ischemic Stroke
10/2013

Drug/Important Bio-Agent (IBA)

1Glutathione (Reduced Glutathione)IBA
05/2022
1TeaIBA
05/2022
1CardenolidesIBA
01/2021
1Pharmaceutical PreparationsIBA
01/2021
1GlycosidesIBA
01/2021
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1alanylalanine (Ala-Ala)IBA
06/2015
1prolyl-proline (Pro-Pro)IBA
06/2015
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
06/2015
1Immunoglobulin E (IgE)IBA
02/2015
1InterferonsIBA
02/2015
1Growth Hormone (Somatotropin)IBA
01/2015
1ZincIBA
01/2014
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2014
1EndopeptidasesIBA
01/2014
1Hemoglobins (Hemoglobin)IBA
12/2013
1ORALIT (ORS)IBA
12/2013
1Triglycerides (Triacylglycerol)IBA
12/2013
1CholesterolIBA
12/2013
1CalciumIBA
12/2013
1LDL CholesterolIBA
12/2013
1HDL CholesterolIBA
12/2013
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
10/2013

Therapy/Procedure

1Drug Therapy (Chemotherapy)
05/2022
1Chemoradiotherapy
01/2021